查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566761

免疫診斷市場：按產品類型、技術、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測

Immunodiagnostics Market By Product Type , By Technology By Application By End-user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年免疫診斷市值為242億美元，預計2024年至2033年複合年成長率為4.1%，到2033年達到364億美元。

免疫診斷是一種利用抗原抗體反應來識別、標靶化和消除病原體和異物的測試。它是檢測多種目標的強大技術，因此在感染疾病和自體免疫疾病檢測、食品安全和癌症診斷領域有重要應用。最常見的免疫診斷技術包括酵素結合免疫吸附檢測法（ELISA）、免疫測量、螢光免疫分析和橫向流動化驗。

全球免疫診斷市場的成長主要是由癌症、心血管疾病和胃腸道疾病等慢性疾病盛行率的驚人成長所推動的。此外，日益嚴重的環境污染以及由於高污染導致的疾病發病率上升正在推動對免疫診斷的需求。免疫診斷工具在二氯二苯基三氯乙烷 (DDT)、多氯聯苯 (PCB)、爆炸物、有機磷農藥和生物戰劑等環境污染物的檢測中發揮重要作用。此外，食品中的污染物（例如葡萄球菌腸毒素 B）以及水果、蔬菜和穀物中的農藥也可以使用免疫診斷方法輕鬆檢測。然而，與免疫診斷相關的高成本以及新興國家不願採用先進技術預計將阻礙市場成長。同時，人們對先進預防醫學的認知不斷提高，診斷試劑套件、檢測方法和分析設備的技術進步預計將為預測期內全球免疫診斷市場的擴張提供利潤豐厚的機會。

全球免疫診斷市場分為產品類型、技術、應用、最終用戶和地區。依產品類型分類，市場分為試劑、儀器、軟體和服務。依技術類型，市場分為酵素結合免疫吸附檢測法、化學冷光免疫檢測、螢光免疫分析、免疫檢測等。依應用細分為感染疾病、腫瘤/內分泌、骨骼/礦物質疾病、自體免疫疾病、心臟生物標記、藥物監測等。依最終使用者分為醫院、臨床檢測實驗室、學術/研究機構等。按地區分類，分為北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按產品類型分類，預計到 2033 年試劑領域將引領市場。

從技術來看，ELISA技術領域將在2023年主導免疫診斷市場。

從應用來看，感染疾病領域可能在預測期內主導市場。

從最終用戶來看，臨床試驗領域可能會在預測期內取得進展。

按地區分類，北美是 2023 年的主要收益來源，在預測期內也可能主導市場。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 國家、區域和全球各級的患者/流行病學資料
  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • SWOT分析

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章免疫診斷市場：依產品類型

  • 市場概況
  • 試劑
  • 檢測設備
  • 軟體和服務

第5章免疫診斷市場：依技術分類

  • 市場概況
  • 酵素結合免疫吸附檢測法
  • 化學冷光免疫檢測
  • 螢光免疫分析
  • 免疫測量
  • 其他

第6章免疫診斷市場：依應用分類

  • 市場概況
  • 感染疾病
  • 腫瘤科 內分泌科
  • 骨礦物質疾病
  • 自體免疫疾病
  • 心臟生物標記
  • 藥物監測
  • 其他

第7章免疫診斷市場：依最終使用者分類

  • 市場概況
  • 醫院
  • 臨床研究所
  • 學術研究所
  • 其他

第8章免疫診斷市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國免疫診斷市場
    • 加拿大免疫診斷市場
    • 墨西哥免疫診斷市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國免疫診斷市場
    • 德國免疫診斷市場
    • 義大利免疫診斷市場
    • 西班牙免疫診斷市場
    • 英國免疫診斷市場
    • 其他歐洲免疫診斷市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國免疫診斷市場
    • 日本免疫診斷市場
    • 印度免疫診斷市場
    • 韓國免疫診斷市場
    • 澳洲免疫診斷市場
    • 其他亞太免疫診斷市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西免疫診斷市場
    • 南非免疫診斷市場
    • 沙烏地阿拉伯免疫診斷市場
    • 其他拉丁美洲/中東/非洲免疫診斷市場

第9章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第10章 公司簡介

  • Abbott
  • Becton Dickinson
  • Agilent Technologies, Inc.
  • Exact Sciences Corporation
  • Guardant Health
  • Illumina, Inc.
  • Diaosorin
  • NeoGenomics Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
簡介目錄
Product Code: A01435

The immunodiagnostics market was valued at $24.2 billion in 2023, and is projected to reach $36.4 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.

Immunodiagnostics are tests that involve the use of antigen-antibody responses to identify, target, and eliminate pathogens or foreign substances. It serves as a powerful technique to detect a wide range of targets and thus finds its major application in the fields of infectious diseases and autoimmune disease detection, food safety, and cancer diagnostics. The most common Immunodiagnostics techniques include enzyme-linked immunosorbent assay (ELISA), radioimmunoassays, fluorescent immunoassays, and lateral flow assays.

The growth of the global immunodiagnostics market is majorly driven by alarming increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal disorders, and other chronic diseases due to vulnerability of geriatric population to such diseases and changes in lifestyle. Furthermore, increase in environmental pollution and rise in incidence of diseases due to high exposure to pollution have boosted the demand for immunodiagnostics. Immunodiagnostic tools play a key role in detecting environmental contaminants such as dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCB), explosives, organophosphorus pesticides, and biological warfare materials. In addition, contaminants in food such as Staphylococcal enterotoxin B as well as pesticides in fruits, vegetables, and grains can be easily detected using immunodiagnostics. However, high costs associated with immunodiagnostics and reluctance in the adoption of advanced technologies in emerging economies are expected to hamper the growth of the market. On the contrary, increase in awareness about advanced preventative health measures and technologically advancements in diagnostic kits, assays, and analyzers are expected to offer remunerative opportunities for the expansion of the global immunodiagnostics market during the forecast period.

The global immunodiagnostics market is segmented into product type, technology, application, end user, and region. Depending on product type, the market is classified into reagents, instruments, and software & services.?As per technology, it is segregated into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, and others. Depending on application, it is fragmented into infectious diseases, oncology & endocrinology, bone & mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and others. By end user, it is categorized into hospitals, clinical laboratories, academic & research institutes, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the reagents segment is expected to lead the market by 2033.

As per technology, the ELISA technology segment dominated the immunodiagnostics market in 2023.

Depending on application, the infectious disease segment is likely to dominate the market during the forecast period.

By end user, the clinical laboratories segment is likely to be lucrative during the forecast period.

Region wise, North America was the major revenue generator in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global immunodiagnostics market include Abbott, Becton Dickinson, Agilent Technologies, Inc., Exact Sciences Corporation, Guardant Health, Illumina, Inc., Diaosorin, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product Type

  • Reagents
  • Instruments
  • Software and Services

By Technology

  • Enzyme-linked immunosorbent assay
  • Chemiluminescence immunoassay
  • Fluorescent immunoassay
  • Radioimmunoassay
  • Others

By Application

  • Infectious diseases
  • Oncology endocrinology
  • Bone mineral diseases
  • Autoimmunity disorders
  • Cardiac biomarkers
  • Drug monitoring
  • Others

By End-user

  • Hospitals
  • Clinical Laboratories
  • Academic research institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Abbott
    • Becton Dickinson
    • Agilent Technologies, Inc.
    • Exact Sciences Corporation
    • Guardant Health
    • Illumina, Inc.
    • Diaosorin
    • NeoGenomics Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Reagents
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Instruments
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Software And Services
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Technology
  • 5.2. Enzyme-linked Immunosorbent Assay
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Chemiluminescence Immunoassay
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Fluorescent Immunoassay
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Radioimmunoassay
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNODIAGNOSTICS MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Infectious Diseases
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Oncology Endocrinology
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Bone Mineral Diseases
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Autoimmunity Disorders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Cardiac Biomarkers
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country
  • 6.7. Drug Monitoring
    • 6.7.1. Key Market Trends, Growth Factors and Opportunities
    • 6.7.2. Market Size and Forecast, By Region
    • 6.7.3. Market Share Analysis, By Country
  • 6.8. Others
    • 6.8.1. Key Market Trends, Growth Factors and Opportunities
    • 6.8.2. Market Size and Forecast, By Region
    • 6.8.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNODIAGNOSTICS MARKET, BY END-USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End-user
  • 7.2. Hospitals
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinical Laboratories
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Academic Research Institutes
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Others
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country

CHAPTER 8: IMMUNODIAGNOSTICS MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product Type
    • 8.2.3. Market Size and Forecast, By Technology
    • 8.2.4. Market Size and Forecast, By Application
    • 8.2.5. Market Size and Forecast, By End-user
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Immunodiagnostics Market
      • 8.2.7.1. Market Size and Forecast, By Product Type
      • 8.2.7.2. Market Size and Forecast, By Technology
      • 8.2.7.3. Market Size and Forecast, By Application
      • 8.2.7.4. Market Size and Forecast, By End-user
    • 8.2.8. Canada Immunodiagnostics Market
      • 8.2.8.1. Market Size and Forecast, By Product Type
      • 8.2.8.2. Market Size and Forecast, By Technology
      • 8.2.8.3. Market Size and Forecast, By Application
      • 8.2.8.4. Market Size and Forecast, By End-user
    • 8.2.9. Mexico Immunodiagnostics Market
      • 8.2.9.1. Market Size and Forecast, By Product Type
      • 8.2.9.2. Market Size and Forecast, By Technology
      • 8.2.9.3. Market Size and Forecast, By Application
      • 8.2.9.4. Market Size and Forecast, By End-user
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product Type
    • 8.3.3. Market Size and Forecast, By Technology
    • 8.3.4. Market Size and Forecast, By Application
    • 8.3.5. Market Size and Forecast, By End-user
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Immunodiagnostics Market
      • 8.3.7.1. Market Size and Forecast, By Product Type
      • 8.3.7.2. Market Size and Forecast, By Technology
      • 8.3.7.3. Market Size and Forecast, By Application
      • 8.3.7.4. Market Size and Forecast, By End-user
    • 8.3.8. Germany Immunodiagnostics Market
      • 8.3.8.1. Market Size and Forecast, By Product Type
      • 8.3.8.2. Market Size and Forecast, By Technology
      • 8.3.8.3. Market Size and Forecast, By Application
      • 8.3.8.4. Market Size and Forecast, By End-user
    • 8.3.9. Italy Immunodiagnostics Market
      • 8.3.9.1. Market Size and Forecast, By Product Type
      • 8.3.9.2. Market Size and Forecast, By Technology
      • 8.3.9.3. Market Size and Forecast, By Application
      • 8.3.9.4. Market Size and Forecast, By End-user
    • 8.3.10. Spain Immunodiagnostics Market
      • 8.3.10.1. Market Size and Forecast, By Product Type
      • 8.3.10.2. Market Size and Forecast, By Technology
      • 8.3.10.3. Market Size and Forecast, By Application
      • 8.3.10.4. Market Size and Forecast, By End-user
    • 8.3.11. UK Immunodiagnostics Market
      • 8.3.11.1. Market Size and Forecast, By Product Type
      • 8.3.11.2. Market Size and Forecast, By Technology
      • 8.3.11.3. Market Size and Forecast, By Application
      • 8.3.11.4. Market Size and Forecast, By End-user
    • 8.3.12. Rest of Europe Immunodiagnostics Market
      • 8.3.12.1. Market Size and Forecast, By Product Type
      • 8.3.12.2. Market Size and Forecast, By Technology
      • 8.3.12.3. Market Size and Forecast, By Application
      • 8.3.12.4. Market Size and Forecast, By End-user
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product Type
    • 8.4.3. Market Size and Forecast, By Technology
    • 8.4.4. Market Size and Forecast, By Application
    • 8.4.5. Market Size and Forecast, By End-user
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Immunodiagnostics Market
      • 8.4.7.1. Market Size and Forecast, By Product Type
      • 8.4.7.2. Market Size and Forecast, By Technology
      • 8.4.7.3. Market Size and Forecast, By Application
      • 8.4.7.4. Market Size and Forecast, By End-user
    • 8.4.8. Japan Immunodiagnostics Market
      • 8.4.8.1. Market Size and Forecast, By Product Type
      • 8.4.8.2. Market Size and Forecast, By Technology
      • 8.4.8.3. Market Size and Forecast, By Application
      • 8.4.8.4. Market Size and Forecast, By End-user
    • 8.4.9. India Immunodiagnostics Market
      • 8.4.9.1. Market Size and Forecast, By Product Type
      • 8.4.9.2. Market Size and Forecast, By Technology
      • 8.4.9.3. Market Size and Forecast, By Application
      • 8.4.9.4. Market Size and Forecast, By End-user
    • 8.4.10. South Korea Immunodiagnostics Market
      • 8.4.10.1. Market Size and Forecast, By Product Type
      • 8.4.10.2. Market Size and Forecast, By Technology
      • 8.4.10.3. Market Size and Forecast, By Application
      • 8.4.10.4. Market Size and Forecast, By End-user
    • 8.4.11. Australia Immunodiagnostics Market
      • 8.4.11.1. Market Size and Forecast, By Product Type
      • 8.4.11.2. Market Size and Forecast, By Technology
      • 8.4.11.3. Market Size and Forecast, By Application
      • 8.4.11.4. Market Size and Forecast, By End-user
    • 8.4.12. Rest of Asia-Pacific Immunodiagnostics Market
      • 8.4.12.1. Market Size and Forecast, By Product Type
      • 8.4.12.2. Market Size and Forecast, By Technology
      • 8.4.12.3. Market Size and Forecast, By Application
      • 8.4.12.4. Market Size and Forecast, By End-user
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product Type
    • 8.5.3. Market Size and Forecast, By Technology
    • 8.5.4. Market Size and Forecast, By Application
    • 8.5.5. Market Size and Forecast, By End-user
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Immunodiagnostics Market
      • 8.5.7.1. Market Size and Forecast, By Product Type
      • 8.5.7.2. Market Size and Forecast, By Technology
      • 8.5.7.3. Market Size and Forecast, By Application
      • 8.5.7.4. Market Size and Forecast, By End-user
    • 8.5.8. South Africa Immunodiagnostics Market
      • 8.5.8.1. Market Size and Forecast, By Product Type
      • 8.5.8.2. Market Size and Forecast, By Technology
      • 8.5.8.3. Market Size and Forecast, By Application
      • 8.5.8.4. Market Size and Forecast, By End-user
    • 8.5.9. Saudi Arabia Immunodiagnostics Market
      • 8.5.9.1. Market Size and Forecast, By Product Type
      • 8.5.9.2. Market Size and Forecast, By Technology
      • 8.5.9.3. Market Size and Forecast, By Application
      • 8.5.9.4. Market Size and Forecast, By End-user
    • 8.5.10. Rest of LAMEA Immunodiagnostics Market
      • 8.5.10.1. Market Size and Forecast, By Product Type
      • 8.5.10.2. Market Size and Forecast, By Technology
      • 8.5.10.3. Market Size and Forecast, By Application
      • 8.5.10.4. Market Size and Forecast, By End-user

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. Becton Dickinson
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Agilent Technologies, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Exact Sciences Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Guardant Health
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Illumina, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Diaosorin
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. NeoGenomics Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Thermo Fisher Scientific Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments